Affiches techniques

  • Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation

    Fezagepras (PBI-4050) Reduces Pulmonary Fibroblast Activation

    Lire le Flipbook
  • Fezagepras (PBI-4050) A Free Fatty Acid Mimetic for the Treatment of NAFLD

    Fezagepras (PBI-4050) A Free Fatty Acid Mimetic for the Treatment of NAFLD

    Lire le Flipbook
  • Fezagepras (PBI-4050) reduces angio-proliferative pulmonary arterial hypertension

    Fezagepras (PBI-4050) reduces angio-proliferative pulmonary arterial hypertension

    Lire le Flipbook
  • Fezagepras (PBI-4050) reverses metabolic dysregulation induced by a high fat diet

    Fezagepras (PBI-4050) reverses metabolic dysregulation induced by a high fat diet

    Lire le Flipbook
  • Plus d'affiches PBI-4050

    Learn More
  • Fatty Acid Receptors GPR40/GPR84: Two Promising Targets in Kidney Fibrosis

    Fatty Acid Receptors GPR40/GPR84: Two Promising Targets in Kidney Fibrosis

    Lire le Flipbook
  • Activation of the Free-fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease Via a Novel EPO-Independent Mechanism of

    Activation of the Free-fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease Via a Novel EPO-Independent Mechanism of

    Lire le Flipbook
  • Activation of the Free-Fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease via a Novel EPO-Independent Mechanism of

    Activation of the Free-Fatty Acid Receptor GPR40 Improves Anemia in Mouse Models of Kidney Disease via a Novel EPO-Independent Mechanism of

    Lire le Flipbook
  • Plus d'affiches GPR40 / GPR84

    Learn More
  • PBI-4547 Prevents Progression of Prediabetic Condition to Type 1 Diabetes in NOD Mice

    PBI-4547 Prevents Progression of Prediabetic Condition to Type 1 Diabetes in NOD Mice

    Lire le Flipbook
  • PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and...

    PBI-4547 Improves Glucose Metabolism and Insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of Obesity and...

    Lire le Flipbook
  • ×

    Inscrivez-vous à notre liste de distribution et soyez les premiers à être informés

    Prénom
    Nom de famille
    En complétant et soumettant ce formulaire, vous comprenez et convenez que l’utilisation du site internet de Liminal BioSciences est sujette à la politique de confidentialité de Liminal BioSciences, incluant le fait que Liminal BioSciences pourrait transférer, à ses affiliés et ses fournisseurs de services, vos informations personnelles recueillies dans le cadre de votre enregistrement sur ce site.
     
    Les données fournies seront utilisées afin que Liminal BioSciences Inc. puisse vous envoyer de l’information concernant les opportunités de carrières et les événements de recrutement.
     
    Les données fournies seront utilisées afin que Liminal BioSciences Inc. puisse vous envoyer de l’information concernant les nouvelles et les mises à jour de la Société et ses filiales.
    !
    Merci!
    Error - something went wrong!
  • PBI-4547 Restores Metabolic Homeostasis in a High Fat Diet Model of Non-Alcoholic Fatty Liver Disease

    PBI-4547 Restores Metabolic Homeostasis in a High Fat Diet Model of Non-Alcoholic Fatty Liver Disease

    Lire le Flipbook
  • PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, -Oxidation and Fibrosis in Liver and...

    PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, -Oxidation and Fibrosis in Liver and...

    Lire le Flipbook
  • Plus d'affiches PBI-4547

    Learn More
  • loading
    Chargement en cours ...